Both in Pharmaceuticals
Nomad Power Solutions vs Heron Therapeutics
Over the past year NMAD returned +1.7% and HRTX returned −6.1%; their daily moves had a correlation of 0.02.
NMAD +1.7% HRTX −6.1%Growth of $1, one year, split-adjusted
| Metric | NMAD | HRTX |
|---|---|---|
| Price | $3.60 | $0.2962 |
| Market cap | $58.0M | $56.2M |
| Today | +1.98% | −12.57% |
| 1 month | +2.1% | +1.8% |
| 6 months | — | −70.4% |
| Year to date | — | −77.2% |
| 1 year | — | −77.2% |
| Revenue growth (YoY) | — | +1.3% |
| Gross margin | — | 69.3% |
| Net margin | — | −14.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.4× |
| Net cash | — | -$100.0M |
| Dividend yield | — | — |
| Volatility (60d) | — | 114.9% |
| Short % of float | 10.5% | 32.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).